Post-approval studies (Phase 4)Ended earlyNCT02253394
What this trial is testing
The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study
Who this might be right for
Pulmonary Arterial Hypertension
Brigham and Women's Hospital 2